NCT02065999 Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients Status COMPLETED Phase N/A
NCT02065713 Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients Status COMPLETED Phase PHASE3
NCT02064920 Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) Status COMPLETED Phase PHASE2
NCT02062502 Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063) Status COMPLETED Phase PHASE3
NCT02062385 Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024) Status COMPLETED Phase PHASE3
NCT02059187 The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006) Status COMPLETED Phase PHASE3
NCT02059174 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005) Status COMPLETED Phase PHASE1
NCT02059161 A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003) Status COMPLETED Phase PHASE3
NCT02057016 Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02055547 A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002) Status COMPLETED Phase PHASE1
NCT02054806 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28) Status COMPLETED Phase PHASE1
NCT02045875 Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence Status COMPLETED Phase PHASE4
NCT02043665 CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) Status COMPLETED Phase PHASE1
NCT02041767 Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration Status COMPLETED Phase PHASE4
NCT02039674 A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) Status COMPLETED Phase PHASE1/PHASE2
NCT02037984 Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) Status COMPLETED Phase PHASE1/PHASE2
NCT02036515 Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2) Status COMPLETED Phase PHASE3